Related Experiment Videos
An immune monitoring program for controlling immunosuppressive therapy
Transplantation Proceedings
|February 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project.
European psychiatry : the journal of the Association of European Psychiatrists·2018
Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery.
The Journal of international medical research·2008
Influence of vaccination and surgery on HLA-DR expression in patients with upper aerodigestive tract cancer.
The Journal of international medical research·2008
Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology.
Transplantation proceedings·2026
Association Between Left Ventricular Geometry and Early Acute Kidney Injury Following Orthotopic Liver Transplantation.
Transplantation proceedings·2026
BK Polyomavirus-Associated Carcinoma In Situ of the Renal Allograft: Balancing Oncologic Control and Graft Preservation.
Transplantation proceedings·2026
Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.
British journal of haematology·2026
iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.
Advances in immunology·2026
Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.
Expert opinion on pharmacotherapy·2026